Works matching IS 02535068 AND DT 2022 AND VI 51 AND IP 2


Results: 13
    1
    2
    3
    4

    Front & Back Matter.

    Published in:
    Blood Purification, 2022, v. 51, n. 2, p. 1, doi. 10.1159/000522358
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11

    Successful Treatment with Belimumab in a Patient with Refractory Systemic Lupus Erythematosus after Initiation of Hemodialysis: Considering the Synergistic Effect of Belimumab and Immunological Burn-Out Phenomenon in End-Stage Renal Disease Patients on Hemodialysis

    Published in:
    Blood Purification, 2022, v. 51, n. 2, p. 182, doi. 10.1159/000512585
    By:
    • Karasawa, Kazunori;
    • Ogura, Shota;
    • Takabe, Tomo;
    • Miyabe, Yoei;
    • Iwabuchi, Yuko;
    • Akiyama, Kenichi;
    • Sato, Masayo;
    • Moriyama, Takahito;
    • Uchida, Keiko;
    • Nitta, Kosaku
    Publication type:
    Article
    12

    Relationships among the Dosage of Erythropoiesis-Stimulating Agents, Erythropoietin Resistance Index, and Mortality in Maintenance Hemodialysis Patients.

    Published in:
    Blood Purification, 2022, v. 51, n. 2, p. 171, doi. 10.1159/000506536
    By:
    • Pan, Sai;
    • Zhao, De-Long;
    • Li, Ping;
    • Sun, Xue-Feng;
    • Zhou, Jian-Hui;
    • Song, Kang-Kang;
    • Wang, Yong;
    • Miao, Li-Ning;
    • Ni, Zhao-Hui;
    • Lin, Hong-Li;
    • Liu, Fu-You;
    • Li, Ying;
    • He, Ya Ni;
    • Wang, Nian-Song;
    • Wang, Cai-Li;
    • Zhang, Ai-Hua;
    • Chen, Meng-Hua;
    • Yang, Xiao-Ping;
    • Deng, Yue-Yi;
    • Shao, Feng-Min
    Publication type:
    Article
    13